Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Immunology · Ethiopia · 2025-05-15

Processing Time
572 days
Decision Date
2025-05-15
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop engineered human immune cell-based therapies to combat immune-mediated diseases such as inflammatory bowel disease, type 1 diabetes, and multiple sclerosis. The work focuses on restoring regulatory T cell (Treg) function to provide innovative treatment options where existing therapies are limited. This research aims to translate methods for engineering immune cells into clinical applications that directly improve human health.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses urgent biomedical challenges and aligns with U.S. interests in improving public health and the biotechnology sector.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and high citation count demonstrate his leadership and influence in the field.

3 Balance of Interests Met

The petitioner's unique skillset and the potential impact of his research make it beneficial for the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biochemistry and a strong scholarly record including 14 peer-reviewed journal articles and 382 citations. Evidence included 8 first-authored abstracts presented at professional conferences and four recommendation letters from leading experts. The case successfully satisfied all three Dhanasar prongs by demonstrating the national importance of treating immune-mediated diseases.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Grants
Conference Presentations
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Clinical Researcher

Research and Development · Jordan

WeGreened EB-2 (NIW) approved
New York 64 days 2025-03-04
The petitioner proposes to continue his research into the mechanistic contributions of T and B cells to the pathogenesis of immunodeficiency and immune dysregulation, aiming to identify and develop novel therapeutics for immunological diseases.
View Case

Postdoctoral Researcher

Pharmaceuticals · Egypt

WeGreened EB-2 (NIW) approved
Tennessee 646 days 2025-11-14
The petitioner proposes to examine immune system dysfunction and its relationship to serious medical conditions to uncover novel immune-targeted treatment strategies. The work focuses on identifying immunological mechanisms that inform the development of new therapeutic strategies for autoimmune disorders, cardiovascular disease, and inflammatory conditions.
View Case

Research Scientist

Biotechnology · Slovenia

WeGreened EB-2 (NIW) approved
New York 64 days 2025-02-24
The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Ethiopia

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-15.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 572 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Ethiopia All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist